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The chemical industry has been put under considerable time pressure by the
EuropeanCommunityRegulationREACH (Registration,Evaluation,andAuthorization
of Chemicals). The work outlined here has been developed at the BASF SE’s
Experimental Toxicology and EcologyUnitwith the objective of promoting a faster
reaction to the testing demand generated by the new legislation. A considerable
increase in forecasted demand for tests has created the necessity to increase the
ToxicologyUnit’s outsourcing activities. The first goalwas to optimize the selection
and management process of Contract Research Organizations (CROs), so that
toxicological studies canbeperformedwithminimal riskwhilemaximizingquality
and cost advantage.A second objectivewas to develop performancemeasurement
system in form of a balanced scorecard to evaluate contracting efficiency by
monitoring major drivers in the outsourcing process to ensure the alignment
between strategic objectives and actual performance.
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strategy for toxicological studies in the
chemical industry
substances.
This paper is a hands-on work, and discusses
how concepts and theoretical approaches are
applied under real conditions and how diverse
tools and methods can be used for strategic
decision-making. Companies are constantly
facing new challenges that come from market
competition and the supply chain as well as
political or economic environments, such as
regulations. These force organisations to change
their operations and processes and to develop
new strategies to survive or grow in a changing
environment.
The first method to be used here is the
Strategic Management Model (Wheelen and
Hunger, 2005), which is the guideline for the
challenges assessment that BASF Experimental
Toxicology and Ecology in following named
1 Introduction
The BASF Experimental Toxicology and
Ecology in Ludwigshafen is a global internal
service provider that performs toxicological
studies for chemical and agrochemical
substances as well as ecological studies for
chemicals.
Because REACH came into force in June 2007,
the demand for registration of all chemical
substances produced in or imported to the
European Union is having a considerable impact
on the BASF SE business units, forcing them to
comply with such new registration requirements
in a short period of time, not only in terms of
workload, demanding new structures and
processes, but also demands a substantial
financial investment in registration of
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monitoring of the results obtained with the
strategic plan. The controlling system ensures
that the strategy deliveries the expected results
or, in this case, that the contracting and
management of service providers are being
conducted efficiently and in alignment with the
strategic objectives.
To address this point, the author Cullen
(2009) has provided her experience with
performance measurement of contracts. The
contract scorecard as defined by her is a balanced
scorecard developed for the context of contract
management. This paper applies it to monitor
the outsourcing performance by evaluating the
activity from different perspectives. It aims to
be a feedback mechanism to the entire lifecycle,
ensuring the strategic objectives achievement
and the process continuous update.
In the end, some of the trade-offs in the
decisions involving outsourcing will be discussed
and the authors will expose their conclusion
and the possible next steps of this work.
2 Current outsourcing strategy of
Toxicology Unit and its results
The contract management team is
responsible for requesting and evaluating
quotations, selecting and contracting service
providers, so called CROs (contract research
organisations) , and ensuring compliance with
international and BASF SE standards, e.g. Animal
Welfare Policy, OECD guidelines for testing, GLP
“Toxicology Unit” has been facing and offers a
structured form to develop a solution.
The author Grönroos (1990) defined the
service concept, which was applied to the
Toxicology Unit’s strategic role and to explain
how it can contribute to improve the outsourcing
activity. Literature researches of outsourcing-
related themes lead to the conclusion that one
of the first industries that operate outsourcing
is the information technology industry. For this
reason, most examples of best practices in this
field have come from authors that have been
studying outsourcing in this industry (see
references).
The authors Power et al. (2008) propose a
method to evaluate the development, or
maturity, level of outsourcing strategies that
helped identify the improvement points in the
current strategy as well as risks pertinent to
outsourcing (Carvusgil et al., 2008). A model
from the US General Accounting Office (2001)
gave inputs to define the outsourcing lifecycle
for toxicological studies. Besides, experiences
from the pharmaceutical industry published on
books (such as Winter and Baguley, 2006) and
on this journal along with inputs from an
external consultant were major drivers to
determine strategic guidelines, to improve the
workflow, to enhance the supplier’s selection
and evaluation and to implement an effective
study monitoring process.
As elucidated by the Strategic Management
Model, an important part of any strategy is the
Table 1 Pre-selection criteria of studies for outsourcing; Source: Contract Management Team
Price/cost ratio
conclusion BASF Group  essential
Number of suppliers
available Value for BASF Group
>130 = 3 A = must have (>5) 
115-130 = 2  yes = 2 0 - 2 = 2 B = nice to have(4-5)
100-115 = 1 maybe = 1 3 - 5 = 1 C = indifferent (2-3)
<100 = 0 no = 0 > 6 = 0 D = outsource (0-1)
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A: Studies receiving more than 5 points are
highly critical and are performed in-house.
They represent the unique strengths of BASF
SE, like screening tests, metabolomics and
special repeated-dose studies
B: Studies receiving 4 or 5 points are studies
of high interest for the Group and are
performed preferably in-house. This category
includes studies where BASF SE is competitive
in price, offers superior experience and there
are few alternative suppliers available.
Particular attention must be paid to
confidentiality agreements
C: Studies receiving 2 or 3 points are standard
studies and have a moderate
price/performance ratio and there are plenty
of suppliers available. The decision of
contracting to a service provider depends on
internal capacity availability
D: Studies receiving less than 2 points reflect
a low interest for the BASF SE. They have a
low price/performance ratio and/or are
expected to be replaced by alternative
methods. Here an active outsourcing strategy
will be applied.
The outsourcing group’s responsibilities also
include:
Communication with internal stakeholders 
Communication with CROs 
Providing specific project information
regarding, for example, deadlines
(Good Laboratory Practice) requirements, and
legal and purchasing guidelines. 
An active system for study portfolio
management has been implemented with the
objective of managing demand fluctuation
through identifying the appropriate types of
study for outsourcing in order to reserve internal
capacity for higher tier studies. 
The studies were evaluated according to three
criteria: 
the ratio between market prices and internal
cost 
the importance for the BASF Group, i.e. the
existence of intellectual property issues (IP)
on substances, a critical aspect for testing
new developments
the number of suppliers (CROs) available for
each expertise field.
On regular meetings between the top
management and technical experts of the
Toxicology Unit, each parameter receives points,
according to the criteria explained above. The
subjectivity of the whole evaluation is minimized
by the definition of clear criteria, i.e. the number
of available suppliers in the respective study
type field. The sum of the given points for the
different criteria leads to the classification of
the studies in four categories (A, B, C and D),
which corresponds to the value for the BASF SE
showed in Table 1. The list of classified studies
has been named Priority List of Studies.
Figure 1 Outsourcing workflow – current state
CRO = Contract Research Organization, SIEF = Substance Information Exchange Forum, REACH = Registration, Evaluation
and Authorization of Chemicals
Source: Contract Management Team
Product Stewardship
Business Units
Contract Team
SIEFs/REACH
CRO
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The contract management strategy will be
critical in maintaining the BASF SE's competitive
advantage by outsourcing services that do not
add technological or economic value to the
Group. By making use of the core competences
of external service providers, it allows a more
flexible and efficient approach towards internal
capacity management. 
Additionally, decision-making based on the
Priority List safeguards the BASF SE's interests
in intellectual property issues on substances,
regarding the study method and test substance
information. Different suppliers’ selection and
contracting approaches are taken depending on
the study classification. In the case of categories
C and D, the focus is set on quality and costs
while for A and B the major concern lies in
maintaining quality and confidentiality in the
external environment. 
The previous strategy was adequate however
it could not be sustainable or efficient in a future
scenario of increasing demand for studies. 
According to the Outsourcing Management
Maturity Model (Power, et al., 2008),
organizations go through different development
stages during an outsourcing program. The
authors’ experience has proved that the faster
an organization learns from its mistakes and
changes the intrinsic behaviours that cause the
mistakes, the better it is positioned to be
successful in the future. 
In the first stage of its outsourcing
development, the BASF SE’s Experimental
Toxicology and Ecology Unit has put in place
many processes to facilitate outsourcing. The
contract team has been formed, strategic
objectives have been set and some processes
such as a selection procedure, contract
facilitation through framework agreements,
invoice management and controlling and the
administration of test substances have been
established. 
However, to deal successfully with the
scenario of increasing demand, the strategy
should be enhanced based on the lessons
learned so far and by applying industry best
practices. 
While the strategic assessment has been
conducted and some parts of the process
defined, the whole lifecycle lacks a complete
integration. Some issues have become critical
to a faster reaction time, such as the previous
workflow, supplier selection and evaluation
processes. 
Provision of test substance and test
substance information
Monitoring of studies; this is the main
mechanism to ensure the desired quality
level and compliance. The study type is the
determining factor for choosing the
appropriate study monitor with the
appropriate expertise.
After a study is concluded with the final
report delivery, the contract management team
collects feedback about the CRO and informs
the sponsor about its performance regarding
the specific study. 
The critical elements of the outsourcing
process are:
1. Suppliers’ selection and evaluation
2. Study monitoring
3. Compliance with the BASF SE standards
4. Monitoring of contract obligations 
5. Management resources assurance 
6. Communication between the involved
parties.
In the past the contract management team,
sponsor (business units) and product
stewardship staff have all requested quotations
independent from each other and placed work
with CROs without sufficient coordination. Figure
1 shows the previous outsourcing workflow.
The outsourcing process shown in Figure 1
has added value to the BASF SE by:
Providing extra capacity without expanding
internal infrastructure and fixed cost:
addressing internal demands without binding
to a long-term investment (in assets and,
mainly, in personal)
Offering an external benchmarking
opportunity to assess internal efficiency and
prices
Providing complementary technical
capabilities: technological competencies in
special niches that differ from those of the
BASF SE’s Experimental Toxicology and
Ecology Unit
Covering other geographic areas: studies
required by regional authorities that must
be conducted locally
Reducing costs: as some services, e.g. acute
studies, may be performed better and/or
cheaper by CROs and this frees up capacity
at the BASF SE’s Experimental Toxicology and
Ecology for performing studies that offer a
better cost margin or are critical to the
organisation 
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obligations
Provide infrastructure to the BASF SE’s
Toxicology Unit to conduct and archive
studies internally
Manage in- and outsourcing activities, which
means:
Providing infrastructure for conducting
studies internally and externally
Being a central point for contracting studies
for internal or external clients
Being a central point for selection,
monitoring and evaluation of suppliers and
contracts.
The following section is dedicated to the
outsourcing process itself, identifying the
outsourcing lifecycle and establishing the
general guidelines for outsourcing to enable a
smoother communication among the
stakeholders and a more efficient process.
3.2 Identifying the outsourcing lifecycle for
toxicological studies
Although outsourcing/off-shoring has the
potential to increase the available capacity and
increase flexibility at an international level, it
also involves many risks, pointed out by experts
in global outsourcing (Cavusgil et al., 2008 and
Power et al., 2008). After studying many
engagements, the authors have concluded that
the main decisions to mitigate such risks involve
defining the strategic outsourcing objectives,
selecting the suppliers based on multiple criteria,
investing in supplier development and
collaboration as well as safeguarding the
sponsor’s interests. 
The outsourcing lifecycle framework is a tool
that provides a step-by-step guide, integrating
the strategic and the operational level of
outsourcing objectives and results. Table 2 has
been developed based on an outsourcing lifecycle
model provided by the US General Accounting
Office (2001). It shows the identified outsourcing
phases for the toxicological studies as well as
the major practices associated with each stage.
This framework allows the visualisation of
all the activities included in the toxicological
services outsourcing process. Besides, it can form
the basis for identifying the optimization points
in the strategy. The focus of this paper is to:
1. Establish the outsourcing guidelines:
communicate the parameters that are
important for its success
2. Improve CRO selection through clear and
multiple criteria and the process itself
3. Establish supplier management: evaluate
3 Enhancing the outsourcing activity 
3.1 Establishing the service vision
A new organizational structure for contract
management was established in the middle of
2010. The establishment of the group’s service
vision helps elucidate its role within the
Toxicology Unit regarding outsourcing activities,
as well as to provide orientation to the
development of an outsourcing strategy and to
facilitate communication of its objectives. The
service concept design has also the potential of
reducing double work, aligning objectives and
stimulating cooperation between stakeholders.
The starting point is the BASF SE’s expectation
of the Toxicology Unit. This issue has been
addressed by the Toxicology Unit’s management
by involving also other main stakeholders like
business units and corporate management. This
research shows that the Unit is expected to:
1. Provide results in time to meet REACH
deadlines;
2. Take responsibility for guaranteeing
compliance of outsourced studies, e.g.
regarding Animal Welfare and GLP; 
3. Take responsibility for guaranteeing
compatibility of study and report quality with
established standards. 
According to the author Christian Grönroos
(1990), the definition of service may depend on
the way the customers or clients interact with
the provider when the client receives the study
final reports and during the process of
production itself – the client is an integral part
of the outcome production; he participates
actively in how, what and when the study is to
be conducted. 
BASF SE’s Toxicology Unit’s mission concept
will be used to determine in which markets it
should operate and which kind of services it
should provide. The basic material for a service
concept development is market research,
conducted through a series of interviews with
the product stewardship and the business units.
Based on this definition, the service vision of
the Service Group aims to:
Understand the clients' needs, how they
perceive value from the BASF SE’s
Experimental Toxicology and Ecology Unit
and how to meet those needs
Guarantee that studies, both in- and
outsourced, are conducted in compliance
with Animal Welfare, GLP and contractual
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Table 2 Outsourcing Lifecycle for pre-clinical testing; Adapted from the US General Accounting Office model (2001)
Phase Objectives Practices
I Plan
Investigate and
elaborate the
sourcing strategy
o Gather experts insights on a variety of sourcing arrangements 
o Benchmark internal services prior to the decision
o Determine goals and expectations
o Collect market intelligence
o Peer/risk assessment
o Estimate impacts on the internal organization
o Define sourcing arrangement
II Define
Operational
Model
Needs’ analysis
o Define strategic objectives
o Create and define contract management structure with operational
...points of contract and managers
o Understand the suppliers’ organizational structure and authority for
....decisions
o Establish outsourcing guidelines
III Select the
suppliers
CROs assessment
o Define selection criteria 
o Gather information from suppliers
o Do audit visits (due diligence process on pre-selected suppliers –   ....Animal
welfare and GLP compliance)
CRO selection
o Establish a matrix for decision with the information gained and ....own
experience
o Establish the selection process
IV Develop the
contract
Contract and
negotiation
management
o Define negotiation strategy
o Establish negotiation team
o Conduct negotiations
o Contract facilitation
o Contract monitoring
V Transition to
CRO
Transfer
responsibility
o Establish work flows 
o Setup governance (structures, roles, authorities)
o Change management
o Knowledge management
VI Operational
phase In life phase
o Place work – request quotes
o Test substance information and pre- existing data. Availability of substance
o Test substance supply, provide Material Safety Data Sheet to suppliers
o Dose selection
o Protocol review & finalise
o In life monitoring 
o Day to Day interactions
o Draft report
o Return comments
o Finalise report
VII Manage
provider(s)
performance
Relationship
management
o Define internal capabilities needed for managing outsourcing
o Establish evaluation team and KPIs 
o Establish mechanisms for  continuous evaluation of suppliers 
o Periodic meetings
VIII Ensure
Services are
provided
Continue or exit?
o Contract outcomes 
o Lessons learned
o Refresh requirements
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3.4Establishing a new management approach
Within large organizations, an unstructured
and inefficient workflow may cause problems
for the outsourcing management. For example:
1. Poor Animal Welfare compliance
2. Loss of control over the number and type
of tested substances, the suppliers used and
the observance of compliance and legal
requirements 
3. Difficult assessment of quality differences
and performance 
4. Different approaches regarding purchasing
and legal aspects
5. Difficulty in reporting to central controlling
There is therefore a high probability that the
overall relationship cost, in terms of time, money
and resources, will outweigh the potential
benefits of working with the CROs. For this
reason, the relationship should evolve to a more
structured one, as shown in Figure 2. A more
centralized outsourcing workflow will help
minimize the risks identified above and will
enable the organisation to achieve its strategic
objectives. The contract management team will
act as a central contact point for outsourcing
activities of toxicological studies at a global
level within the company.  
The previous relationship with suppliers,
where many different members of internal staff
talk to other members of external staff without
prior coordination can be seen in Figure 1. There
is a requirement to move to a structured
relationship, as illustrated in Figure 2 (Winter
and Baguley, 2006). The contract management
team will coordinate the interactions between
technical experts, purchasing, legal, etc. to
optimize the information flow, allowing the
experimental unit to concentrate on performing
studies and to focus on the assessment of
complicated cases that might arise on the
suppliers' side. The key goal is to gain efficiency
through the structure alignment with suppliers
and internal stakeholders. 
An outsourcing management group must
take responsibility for reporting every animal
study to the relevant authorities according to
the BASF SE Animal Welfare policy and rules for
reporting procedure for animal studies (see
Appendix I). A mechanism to guarantee this
compliance is essential. Through this newly
structured workflow the contract management
team coordinates and manages the information
about testing and ensures all company
compliances, bringing some additional benefits:
and monitor performance to develop
relationships further
4. Establish some key performance indicators
(KPI) for performance measurement.
3.3 Establishing the outsourcing model
The strategic decisions in outsourcing have
been stressed in the referenced literature as the
most important ones, forming the starting point
to determine the outsourcing arrangement and
to identify potential suppliers. Some aspects
have to be considered in these decisions, like
the study complexity and its operational impact
as well as the strategic importance for the
business. To guide this assessment, a recent
report published in the Journal of Business
Chemistry (Festel et al., May 2010) showed the
different levels of cooperation models used in
the pharmaceutical industry, which are similar
to the toxicological studies in the chemical
industry.
According to this report, the pharmaceutical
industry invests much management time and
capacity in choosing appropriate service
providers to achieve goal congruence.
Inspections of the suppliers’ facilities, quality,
best practices, trained staff and certified
processes are crucial in the selection process,
as well as the assessment of their financial
stability. 
The principles of risks mitigation (Cavusgil
et al., 2008) and the outsourcing model are the
basis for establishing guidelines for an
outsourcing strategy. The following aspects have
been identified as critical for the success of the
strategy and therefore should be followed by
the whole company:
Animal Welfare compliance by suppliers is a
long-term critical aspect
Adherence to all agreed and established
outsourcing processes by stakeholders
Observance of stakeholders’ accountabilities
Compliance with a clear accreditation process
Use of preferred and approved CROs only, at
a global level considering regional needs
Regional placement of work is allowed only
with accredited CROs and through a process
established by the global contract
management team
Establishment of internal contact points to
each project
Definition of governance structures in the
process
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Clear standards
Selection, evaluation and control of suppliers
according to these standards and
expectations
Appropriate and clear penalty
Global coverage
Selection criteria have be set to evaluate the
suppliers’ competencies in delivering the
services, transforming (supplier’s ability to deliver
improved service both in terms of quality and
cost) and building a relationship (also called
“easy-to-work” competency, it includes the
supplier’s willingness and ability to design its
business model to the values, goals and needs
of the customer) (Oshri et al., 2009). Based on
the risk mitigation principle, these criteria,
determined by the technical experts and the
business specialists from the Toxicology Unit,
form the technical and non-technical reference
for the evaluation of the suppliers’
competitiveness, technical capabilities and
capacities, investment plans and robustness
from a long-term perspective. 
A questionnaire, based on the criteria shown
in Table 3, was developed to deliver information
in four areas (Appendix II gives the main topics).
CROs completed it with their data regarding
scientific expertise and experience, financial
development and projections, human resources
management approach, and company market
focus. The data will flow to a supplier matrix
and will generate a supplier ranking that will
Compliance assurance with legal and
procurement guidelines
More transparency of the outsourcing process
Contract facilitation
Increase in supplier management
effectiveness 
Facilitation of the establishment of a global
outsourcing team 
3.5 Improving the CROs selection process
Similar to a marriage, the supplier selection
strategy should be designed to lead to a long-
term, mutually beneficial relationship. Selecting
the right supplier for each study type or technical
discipline is essential to maximize the benefits
and minimize the risks and costs associated with
contracting out. 
After having chosen a multisourcing model,
i.e. the use of more than one CRO (Oshri et al.,
2009), the next step will be to choose the criteria
to select suppliers, considering the critical criteria
to ensure the desired service level for the
sponsor. It also represents a potential
opportunity for the development of a sustainable
supply chain management, as there is growing
concern from the public about how companies
are dealing with social standards and obligations
such as animal testing, as reported in an article
in the Journal of Business Chemistry (Peukert
and Sahr, May 2010). In this sense, a sustainable
procurement has to include, among other
factors:
Figure 2 Outsourcing flow diagram – desired state
Product Stewardship Business Units
Contract
Management
SIEFs/REACH
Experimental Toxicology
and Ecology
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Table 3  Criteria for CRO selection
Selection criteria Evaluation object 
(First)
information
source 
Weighting Update
Animal welfare Animal Welfare compliance "level"
Animal Welfare
questionnaire +
audits
5
After audit visit
and monitoring
visits
GLP Existence of GLP-OECD or nationalcertificates
GLP Certificate +
audits 4
After audit visit
and monitoring
visits
Scientific expertise Technical expertise areas Questionnaire 3 Annually
Terms & conditions Degree of difficulty in reaching aMaster Agreement Experience 4 Annually
Regulatory
acceptance Compliance to guidelines (OECD) Certificate 3 Annually
# of studies
performed Experience level Questionnaire 3 Annually
# of experts on site Scientific capacity on site Questionnaire 3 After audit visit
Price ratio Price level compared to BASFExperimental Toxicology and Ecology Quotation 2 Annually
Liquidity/financials Financial sustainability Questionnaire,internet, reports 2 Annually
Broadness of
technical capability 
Investment to develop special
features Questionnaire 1 Annually
Human resources
(training) Importance of personnel training Questionnaire 1 After audit visit
Capacity/year 5
(employees; fast
accessibility)
Capacity utilization level Questionnaire 1 Annually
Table 4 Criteria importance level and its implication for suppliers’ accreditation
Weighting Importance level Implication
5 essential PREFERRED (only for scores 4 and 5)
4 critical NOT ACCEPTABLE (for scores 1 and 2)
3 very important NOT ACCEPTABLE (for scores 1 and 2)
2 important evaluation from 1-5
1 not critical evaluation from 1-5
form the basis for selecting companies that will
be audited for Animal Welfare and GLP
compliance, along with technical competence
evaluation, a procedure that assures a
transparent and sustainable outsourcing process,
saving valuable time and money.
The questionnaire and Animal Welfare
checklist improve the quality of the collected
information and acts as a preparation for an
audit visit . The audit of selected CROs
(considering, for example, expertise, location
and recommendations) is to be conducted by a
team, normally comprising an internal technical
expert (or experts), the Animal Welfare specialist
(or officer) and a member of the contract
management team (responsible for business
criteria).
After the audit visit, scores for Animal Welfare
and GLP compliance will be assigned to the
supplier and determine if it can be accredited.
The scoring system works according to a
punctuation principle: the contract management
team establishes to each criterion receives a
weight between one and five.  The weighting
value of each criterion represents an objective
form of quantification of its importance level
in achieving the desired effectiveness of the
outsourcing activity. As shown in Table 4 below,
essential aspects for the outsourcing success
receive the higher weight value 5. A regular
revision of this weighting system ensures that
the contracting of suppliers is being conducted
according to the risk mitigation principle
mentioned above.
The evaluation team gives to each criterion
a score from one (very bad) to five (very good),
and the product of the two dimensions (weight
x score) results in a total score for the CRO. The
score ranking indicates which CRO is closer to
the “ideal” supplier, the one that would receive
the greatest possible total score. 
The suppliers are classified into four
categories in the Supplier Matrix: preferred,
approved, marginal and not acceptable suppliers,
as summarized in Table 5. Depending on the
attributed importance level, the supplier must
receive a score of at least 4 to be accredited as
a preferred supplier (see Table 4). An example
is the Animal Welfare evaluation. This evaluation
system also delivers study specific information,
considering differences in compliance levels and
quality of one supplier. 
Before the placement of any studies with a
CRO, a Terms and Conditions (T&C) Agreement
should be in place with the preferred and
approved CROs, to avoid any potential future
legal or relationship issues. It is recommendable
to select at least one preferred supplier for each
technical area or discipline.
3.6 Continuous evaluation of suppliers
A further important step in outsourcing risk
mitigation is the continuous evaluation of
suppliers’ performance. Feedback should be
collected after each study/project conclusion
based on evaluation according to a defined set
of criteria. The evaluation criteria comprises
technical and non-technical aspects, focusing
on study parameters like quality, delivery on
time, project management and cost deviation.
The evaluation criteria and respective
importance level are shown in Table 6. The study
monitor provides feedback on the supplier
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Category Final score Definition Decision
Preferred 128 - 160 Best combination of expertise, qualityand price. T&C agreed. First choice 
Approved 96 - 127 Technically competent Second choice
Marginal 65 - 95 Not sufficient information or quality,GLP or Animal Welfare are OK.
Complement data before
placing studies 
Not acceptable < 64 Critical issue(s) Do not place studies
Table 5 Classification of suppliers based on the CRO ranking points; Source: Contract Management Team
performance by attributing a score between one
and five to each criterion. The product between
score and weight will generate the total score
that the CRO reached for the specific study type
(the same as for the selection process). 
This second stage provides information for
the annual Supplier Matrix update, together
with other factors such as staff movements, new
competitors or price changes. Another key
advantage is that it generates a performance
databank, enabling comparisons between
different suppliers and different study types. 
Regular meetings involving both the sponsor
and CRO representatives should take place,
depending on the volume and frequency of work
placed with the supplier. This should be a forum
for discussions about the issues highlighted in
the evaluation and is designed to contribute to
the on-going relationship development with the
supplier. For major suppliers it is recommended
that reviews take place more often. Supplier
meetings should:
Provide an arena for dialogue between
suppliers and clients at both team and senior
level
Encourage mutual understanding of roles
and responsibilities, goals and objectives
Promote knowledge sharing based on
objective metrics, surveys and lessons
learned.
The benefits of such forums can be
experienced by both partners. Good performance
can be transferred to other study types and/or
CROs. Conversely, bad performance, unrealistic
requirements, outdated performance indicators,
portfolio changes, current and potential pricing
changes, etc., should be discussed in these
meetings as the basis of corrective and
preventive actions. The lifecycle can be improved
through activating the controlling mechanisms,
and the stage where the lifecycle re-starts
depends on the action required. 
3.7 Defining metrics for the outsourcing
performance measurement 
It is not sufficient to understand how efficient
and well a supplier performs studies but also
how effective the relationship is or to what
extent the relationship brings added value to
the sponsor. 
Performance measurement is a critical
element to any strategy; it acts as a “reality
check” between the planned strategic objectives
and the results. The principle of “what is
measured is managed” highlights that KPIs
provide a realistic picture of what is in place and
allow strategic and tactical corrections. The
author Sara Cullen (2009) proposes performance
evaluation through a contract scorecard – a
balanced scorecard in the context of the contract
management. It is composed of four quadrants:
quality, finance, relationship and strategy, as
illustrated in Figure 3. 
Some KPIs have been defined to monitor the
supplier selection and evaluation processes, e.g.
study quality, study and report deadlines as well
as project management evaluation. They are the
essential measurement points of both output
quality and the efficiency of the relationship.
The study monitoring effort represents another
critical factor for success of outsourcing. The
scores attributed by the study monitors are the
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Table 6 Evaluation criteria of CROs after study conclusion
Evaluation criteria Evaluation object Weighting
Study quality Quality of outcome 4
Deadline compliance report Report on time 4
Study monitoring effort Level of monitoring needed 2
Deadline compliance study Results on time 2
Project management Cooperation (easy to work with), projectmanager (study director) performance 2
Project cost deviation Quotation effectiveness 2
Logistics Custom/transportation efforts 2
basis for a qualitative measurement. A ratio
between the cost of personal dedicated to study
monitoring and the number of studies
outsourced is included in the finance quadrant
of the scorecard because it quantifies the
demanded effort level to monitor studies. 
Still with regard to financial performance,
the transaction cost is included in the quadrant
as a metric of outsourcing efficiency. The CRO
cost and the additional internal costs incurred
to manage the outsourced studies should not
be higher than the internal cost of performing
the study in-house. If the internal and external
costs are equal, it is not worthwhile outsourcing
from an economic perspective.
A further financial measure that is included
in the scorecard is the project cost deviation,
indicating the planned and the actual amount
spent. Additional KPIs to measure the
outsourcing efficiency are required to monitor
the cost evolution of the contract management:
the increase in the contract management team
costs in comparison to the increase in the total
contract budget as well as a ratio between the
contract-out team cost and the outsourcing
volume.
With the gathered information about internal
costs and the suppliers’ quotation the margin
generated in each outsourcing transaction can
be calculated. This reveals a potential cost
reduction in some outsourced study types.
However, other studies have to be outsourced
due to a lack of internal capacity. In these cases,
cost reduction is not the major driver and the
outsourcing may even have an acceptable
negative cost impact. The internal additional
management and monitoring effort are not
compensated by the small margin. In some cases,
it is necessary to absorb extra costs to gain extra
capacity and ensure the required study delivery
for the internal clients.
4 Evaluating trade-offs
The additional monitoring costs are one of
the trade-offs to be balanced when outsourcing
toxicological studies. The costs estimated for
studies required by REACH do not take into
consideration the additional internal resources
required for work placement and monitoring,
which involves additional personal in the
contract management team and the capacity
increase through external consultants. How will
the current monitoring costs develop with the
new structure? 
Increasing internal personal levels at a higher
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Figure 3 The proposed balanced scorecard 
Based on the contract scorecard model, Sara Cullen (2009). The contract scorecard: successful outsourcing by
design
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rate than the increased volume demand for work
may demonstrate that contract management
costs can be higher than predicted. However,
the workflow centralization could decrease costs
in other areas, e.g. product stewardship and
business units, or could free up capacity in these
areas for other tasks: a sort of cost transfer. An
alternative strategy could be the increase of
internal study capacity. However, physical space
for laboratory expansion would involve
significant financial investment and the pay-
off in the long run may not be high enough. The
buildings cannot accommodate more equipment
or personal, which means that an expansion
would be much more costly than only hiring
new technicians. It would require significant
investment in infrastructure, involving not only
the construction of a new building, but also
additional infrastructure for animal feed storage,
pathology, etc. Besides, another factor is the
time required.
5 Conclusion 
State-of-the-art literature and industry best
practices have helped to develop further the
strategy and some factors can be identified as
critical for its success. The entire outsourcing
lifecycle has experienced a much higher level of
activity, which demands closer monitoring and
coordination in order to keep it aligned with the
strategic objectives. The changes also rely on a
more centralized workflow that requires extra
resources to be put into place, for example
additional capacity to monitor studies. 
The establishment of outsourcing guidelines
in the field of toxicology impacts not only local
teams but also regional businesses. As the local
processes have already been defined and
implemented, they have to be adapted to the
regional conditions and structures, so that, in
addition to the existing guidelines on
compliance (e.g. Animal Welfare), the
organizational standards can be globally
followed. Strategy coordination and study
placement monitoring worldwide generates an
additional workload.
An important information source was the
questionnaire, developed during this work to
obtain information about the CROs regarding
the most important aspects for selection and
evaluation. Combined with the Animal Welfare
questionnaire, it acts as a basis for decision-
making when selecting new suppliers, delivering
information to the organization about the
supplier’s capabilities and strengths.
The supplier matrix represents a further
potentially sensitive point for internal staff,
because it depends on the understanding and
adoption by the contract management team
and study monitors. To ensure the system’s
effectiveness, the people that interact with CROs
must feed it with accurate information and
update it regularly. The evaluation system is
essential for supplier management, because it
provides information about their performance
and enables corrective actions. 
The supplier matrix and performance
evaluation concepts are dynamic systems. As
the process evolves, KPIs can become irrelevant
while others can be augmented to help the
organization improve its efficiency and therefore
should not represent an extra workload but have
a direct benefit. A next step would be to define
the desired standards for each metric and follow
them periodically.
Appendix I - BASF SE animal welfare
policy (extract thereof) 
BASF´s animal testing is conducted according
to legal requirements and [in Germany] in
compliance with the German Animal Welfare
Act, and the relevant EU directives. Furthermore,
BASF is committed to high ethical and scientific
animal welfare standards. Its experimental
toxicology and ecology unit is accredited by
AAALAC (Association for the Assessment and
Accreditation of Laboratory Animal Care). Most
of the practical work with animals is carried out
by BASF’s Experimental Toxicology and Ecology.  
In those cases where BASF needs to
commission animal studies to external contract
research organisations, scientific and animal
welfare monitoring is performed by experts of
BASF’s Product Safety to ensure that our internal
ethical and animal welfare standards are
maintained on a global level. 
Appendix II - Suppliers’ questionnaire 
Supplier’sName: 
Contact person: 
Function: 
1. Human resources
We would like to gain an overview of the human
resources in your company, i.e. number of
employees dedicated to the different fields.
Please specify number of scientists and technical
staff.
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a) What educational background do the Study
Directors have? 
b) How are the technical experts trained?
2. Expertise and experience
We would like to gain further information about
the technical expertise and experience of your
company.
a) How long have you been performing studies? 
Toxicological                       years
Ecotoxicological                      years
b) How many studies (per type) are performed
a year?
c)Please indicate the 3 main areas in which your
company specializes.  
d) In which areas do you consider your company
to be most competitive? 
3. Economics
We would like to gain an insight into the size
and financial performance of your company.
a) Please indicate in percent the revenue
distribution of your company for the industries
and regions quoted.
b)How has your company developed financially
over the last 5 years? 
4. Technology development
We would like to gain an overview of investment
plans on pre-clinical testing for the next years.
5.Market information
a) Please estimate your percentage of market
share in the regions.
b) Please indicate in percent your expectation
for development over the next five years.
c) Is REACH impacting your business? How?
6. Additional comments
This section may be utilized for any additional
comments and/or site-specific information
regarding your company.
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